Pharmacyte Biotech Inc (PMCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 01-2022 | 10-2021 | 07-2021 | 04-2021 | 01-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,817 | -2,005 | -1,025 | -3,551 | -2,591 |
| Accounts payable and accrued liabilities | -79 | -15 | -7 | -14 | -107 |
| Other Working Capital | -213 | -708 | -276 | -146 | -215 |
| Other Operating Activity | 184 | 101 | 67 | 380 | 522 |
| Operating Cash Flow | $-2,926 | $-2,627 | $-1,241 | $-3,331 | $-2,391 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 87,362 | 87,362 | N/A | 4,699 | 4,699 |
| Other Financing Activity | 0 | 0 | 0 | -62 | -113 |
| Financing Cash Flow | $87,362 | $87,362 | $N/A | $4,637 | $4,586 |
| Exchange Rate Effect | 1 | 1 | -2 | 1 | 1 |
| Beginning Cash Position | 2,202 | 2,202 | 2,202 | 895 | 895 |
| End Cash Position | 86,640 | 86,939 | 959 | 2,202 | 3,091 |
| Net Cash Flow | $84,438 | $84,737 | $-1,243 | $1,307 | $2,196 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,926 | -2,627 | -1,241 | -3,331 | -2,391 |
| Free Cash Flow | -2,926 | -2,627 | -1,241 | -3,331 | -2,391 |